Behind the science
'Prevention is the best medicine to stop disease before it starts'
What does it mean to get ahead of disease by focusing on prevention, intervening earlier, and more effectively? Here, the GSK team explains why a prevention-powered approach to health is the best investment not just for patients, but for the world’s health systems and economies.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
















